The HYPE Buyback Lie Everyone's Selling

# The HYPE Buyback Lie Everyone's Selling

Let's get the headline out of the way, because it's a doozy: Hyperliquid just fired up a machine that routes roughly 90% of cost-adjusted USDC reserve yield into a fund that buys back its own token. On paper that's a beautiful, self-fueling loop — a perpetually running bid sourced from the stablecoin reserves parked on its own exchange. And it's real. The AQAv2 framework activated August 26, 2026, after governance passed it on June 12. Circle and Coinbase each staked 500,000 HYPE to get it moving. This isn't vaporware.

So why am I about to be the guy who ruins it for you?

Because the version of this story circulating in the crypto press has a fat, seductive error baked into the copy-paste headlines: they call it a buy-and-burn. It isn't, yet. The October 3 payout — the first of a recurring schedule — is a purchase, and the fund holds those tokens. That removes HYPE from active circulation, sure, but a permanent supply reduction is a separate, later step that requires approved protocol action nobody has taken. Until someone clicks burn, you're looking at a warehouse of HYPE, not a deflating balloon. The press that ran "buy-and-burn" oversold the certainty of supply destruction by a wide margin.

Here's what I actually think is going on.

The bull case is genuinely strong, and I'll say so. Hyperliquid has blown past 1.2 million users and ~$4.33 trillion in cumulative volume. Spot ETFs from Bitwise (BHYP) and 21Shares (THYP) launched and reportedly pulled ~$25.5 million in a single session. Grayscale is reportedly in talks to seed a staking ETF with ~$115M of HYPE. Goldman Sachs has a position. A venue trading at a 14x revenue multiple against 35–50x comparables like Robinhood and Interactive Brokers is, on its face, a cheap name in a hot market. The market even put an 80% implied probability on HYPE clearing $90 by year-end.

And as of our own snapshot Friday evening, HYPE-USD was hovering near $91.93, up 11% on the day, ranked #9 by market cap. The tape is doing the talking.

Now the part the bulls want you to skip.

You don't get to ignore the valuation math. The fully diluted valuation sits around $56.7 billion against a much smaller circulating float. That gap isn't academic — it's a floor of future unlocks quietly sitting overhead. Our own calendar lists an unlock event around November 29 that some sources peg as large; it's unverified, so I won't scream it from the rooftops, but the structural overhang is real whether or not that specific date holds.

And the numbers themselves are sand. Reports on cumulative buyback spending range from ~$945 million removing 15% of circulating supply to "$1.1–2.0 billion in some estimates" to "40 million tokens retired." Pick your source, get your number. The projected $135–160 million (up to ~$303 million at a 5% yield) annual contribution is not an official forecast from Hyperliquid — it's a sensitivity table built on assumptions about reserve size and yield that could both move against you. The protocol has confirmed no fixed payment and no guaranteed yield.

Then there's the positioning. Open interest in futures has surged toward $3.58 billion. That's fuel in both directions. Heavy leverage plus a narrative that's already run hard means the next sharp move could be a liquidation cascade, not a fundamental re-rating.

So where does that leave us?

My read: HYPE is a legitimate, high-conviction momentum story with a real revenue engine behind it — but the market has priced it like a guaranteed deflationary compounding machine when the mechanics are weaker than the headlines claim. The buyback is a bid, not a burn. The revenue is a projection, not a promise. And the FDV is a sword hanging over every "cheap multiple" argument.

I'd rather own the nuance than the headline. If you're long, size like the unlocks are coming, because they are. If you're on the fence, respect that you're buying a narrative that's already 80% priced into an 80%-likely-to-hit target. The machine is real. The marketing is not.